» In vitro evaluation of the aerosol performance of drug formulation and different nebulizer configurations
» Use of existing eFlow® Technology platform components
» Clinical development / in human studies
» Re-engineering or new development of device components
» Exclusive access to the eFlow® Technology platform
» Support of submission, approval and launch of the drug-device combination product
Contact us
Do you have any questions about our technology, partnering approach and services?
Please contact us!
eFlow-partneringpari.com
© 2024 PARI GmbH Spezialisten für effektive Inhalation